1200442-07-4Relevant academic research and scientific papers
Potent and orally active small-molecule inhibitors of the MDM2-p53 interaction
Yu, Shanghai,Qin, Dongguang,Shangary, Sanjeev,Chen, Jianyong,Wang, Guoping,Ding, Ke,McEachern, Donna,Qiu, Su,Nikolovska-Coleska, Zaneta,Miller, Rebecca,Kang, Sanmao,Yang, Dajun,Wang, Shaomeng
, p. 7970 - 7973 (2009)
We report herein the design of potent and orally active small-molecule inhibitors of the MDM2-p53 interaction. Compound 5 binds to MDM2 with a K i of 0.6 nM, activates p53 at concentrations as low as 40 nM, and potently and selectively inhibits
Spiroindolinone Derivatives
-
Page/Page column 12, (2010/08/22)
There are provided compounds of the formula or a pharmaceutically acceptable salt or ester thereof wherein X, Y, R1, R2 are as herein described. The compounds have utility as antiproliferative agents, especially, as anticancer agents
SPIROINDOLINONE DERIVATIVES
-
Page/Page column 48, (2008/06/13)
The present invention relates to spiroindolinone derivatives of the formula and their enantiomers and pharmaceutically acceptable salts and esters thereof wherein R1, R2, R3, R4, R5, R6, R7 and R8, are as herein described.
